CLINICAL_TRIALS
trial_result
· 2016-12-07
Clinical Trial Update: A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Summary
Phase 2 trial update for TD-4208 in COPD completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mylan Inc. | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2016-12-07